Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition

In the first major workforce reduction disclosed under new CEO Belén Garijo, Sanofi is laying off 229 employees from legacy Blueprint Medicines in Massachusetts as part of a post-acquisition integration.